149 related articles for article (PubMed ID: 29689063)
1. Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population.
Abdollahpour I; Nedjat S; Mansournia MA; Schuster T
PLoS One; 2018; 13(4):e0196244. PubMed ID: 29689063
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Marginal Causal Effect of Fish Consumption during Adolescence on Multiple Sclerosis: A Population-Based Incident Case-Control Study.
Abdollahpour I; Nedjat S; Mansournia MA; Sahraian MA; Kaufman JS
Neuroepidemiology; 2018; 50(3-4):111-118. PubMed ID: 29734162
[TBL] [Abstract][Full Text] [Related]
3. Estimating the Marginal Causal Effect and Potential Impact of Waterpipe Smoking on Risk of Multiple Sclerosis Using the Targeted Maximum Likelihood Estimation Method: A Large, Population-Based Incident Case-Control Study.
Abdollahpour I; Nedjat S; Almasi-Hashiani A; Nazemipour M; Mansournia MA; Luque-Fernandez MA
Am J Epidemiol; 2021 Jul; 190(7):1332-1340. PubMed ID: 33576427
[TBL] [Abstract][Full Text] [Related]
4. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
5. Stress-full life events and multiple sclerosis: A population-based incident case-control study.
Abdollahpour I; Nedjat S; Mansournia MA; Eckert S; Weinstock-Guttman B
Mult Scler Relat Disord; 2018 Nov; 26():168-172. PubMed ID: 30268037
[TBL] [Abstract][Full Text] [Related]
6. Parental ethnicity associated with risk for multiple sclerosis: A population-based incident case-control study in Iran.
Abdollahpour I; Nedjat S; Mansournia MA; Sahraian MA; Asgari N
Mult Scler Relat Disord; 2018 Feb; 20():100-103. PubMed ID: 29353734
[TBL] [Abstract][Full Text] [Related]
7. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
[TBL] [Abstract][Full Text] [Related]
8. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
9. Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study.
Abdollahpour I; Nedjat S; Mansournia MA; Eckert S; Weinstock-Guttman B
Acta Neurol Scand; 2018 Oct; 138(4):308-314. PubMed ID: 29740825
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle factors and multiple sclerosis: A population-based incident case-control study.
Abdollahpour I; Nedjat S; Mansournia MA; Sahraian MA; van der Mei I
Mult Scler Relat Disord; 2018 May; 22():128-133. PubMed ID: 29677591
[TBL] [Abstract][Full Text] [Related]
11. Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control Study.
Abdollahpour I; Lizarraga AA; Nedjat S; Mansournia MA; Weinstock-Guttman B
Neuroepidemiology; 2019; 52(1-2):55-62. PubMed ID: 30476926
[TBL] [Abstract][Full Text] [Related]
12. No association between socioeconomic status and risk of multiple sclerosis: A population-based incident case-control study in a developing country.
Abdollahpour I; Nedjat S; Salimi Y; Moradzadeh R; Mansournia MA; Sahraian MA; Shokoohi M
Mult Scler Relat Disord; 2018 Oct; 25():292-296. PubMed ID: 30172171
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.
Guimond C; Lee JD; Ramagopalan SV; Dyment DA; Hanwell H; Giovannoni G; Criscuoli M; Yee IM; Vorobeychik G; Ebers GC; Sadovnick AD
Mult Scler; 2014 Aug; 20(9):1182-8. PubMed ID: 24414537
[TBL] [Abstract][Full Text] [Related]
15. Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study.
Alsharie AM; Rafiee F; Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2021 Jun; 51():102937. PubMed ID: 33857898
[TBL] [Abstract][Full Text] [Related]
16. Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity.
Brosseau L; Philippe P; Méthot G; Duquette P; Haraoui B
Neuroepidemiology; 1993; 12(1):6-14. PubMed ID: 8327025
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of risk factors for multiple sclerosis in Iran.
Alonso A; Cook SD; Maghzi AH; Divani AA
Mult Scler; 2011 May; 17(5):550-5. PubMed ID: 21325015
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
19. Waterpipe smoking associated with multiple sclerosis: A population-based incident case-control study.
Abdollahpour I; Nedjat S; Sahraian MA; Mansournia MA; Otahal P; van der Mei I
Mult Scler; 2017 Sep; 23(10):1328-1335. PubMed ID: 27834737
[TBL] [Abstract][Full Text] [Related]
20. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
